The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Patel, Maulikkumar Ashokbhai
    Director born in August 1980
    Individual (12 offsprings)
    Officer
    2015-10-02 ~ dissolved
    OF - director → CIF 0
    Patel, Maulikkumar
    Individual (12 offsprings)
    Officer
    2015-10-02 ~ dissolved
    OF - secretary → CIF 0
    Mr Maulikkumar Patel
    Born in August 1980
    Individual (12 offsprings)
    Person with significant control
    2016-04-06 ~ dissolved
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

ALAN PHARMA LTD

Standard Industrial Classification
96090 - Other Service Activities N.e.c.
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Property, Plant & Equipment
1,122 GBP2017-10-31
1,402 GBP2016-10-31
Fixed Assets
1,122 GBP2017-10-31
1,402 GBP2016-10-31
Debtors
12,295 GBP2017-10-31
7,357 GBP2016-10-31
Cash at bank and in hand
69,198 GBP2017-10-31
36,502 GBP2016-10-31
Current Assets
81,493 GBP2017-10-31
43,859 GBP2016-10-31
Net Current Assets/Liabilities
70,781 GBP2017-10-31
19,031 GBP2016-10-31
Total Assets Less Current Liabilities
71,903 GBP2017-10-31
20,433 GBP2016-10-31
Creditors
Non-current
-8,902 GBP2017-10-31
Net Assets/Liabilities
63,001 GBP2017-10-31
20,433 GBP2016-10-31
Equity
Called up share capital
1 GBP2017-10-31
1 GBP2016-10-31
1 GBP2015-10-31
Retained earnings (accumulated losses)
63,000 GBP2017-10-31
20,432 GBP2016-10-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
42,568 GBP2016-11-01 ~ 2017-10-31
20,432 GBP2015-11-01 ~ 2016-10-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
1,753 GBP2017-10-31
1,753 GBP2016-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
631 GBP2017-10-31
351 GBP2016-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
280 GBP2016-11-01 ~ 2017-10-31
Property, Plant & Equipment
Plant and equipment
1,122 GBP2017-10-31
1,402 GBP2016-10-31
Trade Debtors/Trade Receivables
Current
12,295 GBP2017-10-31
7,357 GBP2016-10-31
Trade Creditors/Trade Payables
Current
4,738 GBP2016-10-31
Corporation Tax Payable
Current
10,712 GBP2017-10-31
Amounts owed to directors
Current
20,090 GBP2016-10-31
Non-current
8,902 GBP2017-10-31
Nominal value of allotted share capital
Class 1 ordinary share
1 GBP2016-11-01 ~ 2017-10-31
Number of shares allotted
Class 1 ordinary share
1 shares2016-11-01 ~ 2017-10-31

  • ALAN PHARMA LTD
    Info
    Registered number 09805611
    C/o Bbk Partnership, Crown House, 2a Ashfield Parade, Southgate, London N14 5EJ
    Private Limited Company incorporated on 2015-10-02 and dissolved on 2018-11-22 (3 years 1 month). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.